Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration recently issued a final guidance, entitled “Compounding Animal Drugs from Bulk Drug Substances,” that will help protect animal health by recognizing …
FDA Issues Final Guidance on Animal Drug Compounding from Bulk Drug Substances Read More
WASHINGTON, D.C. — Data from two new CDC reports show COVID-19 vaccine boosters remain safe and continue to be highly effective against severe disease over time.
New CDC Studies: COVID-19 Boosters Remain Safe, Continue to Offer High Levels of Protection Read More
WASHINGTON, D.C. — The following quote is attributed to Acting FDA Commissioner Janet Woodcock, M.D.:
FDA Takes New Steps Aimed at Advancing Development of Individualized Medicines to Treat Genetic Diseases Read More
WASHINGTON, D.C. — The following quote is attributed to Theresa M. Michele, M.D., director of the Office of Nonprescription Drugs in the FDA’s Center for Drug Evaluation and Research:
FDA Posts an Initial Batch of Four Deemed Final Administrative Orders for Over-the-Counter Drugs Read More
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) this week announced that it has received a written pre-investigational new drug (pre-IND) response from the U.S. Food and Drug Administration (FDA) …
Virpax Pharmaceuticals Receives FDA Response and Guidance on MMS019 Read More BERWYN, PA — Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) has provided a progress update on its pipeline of product candidates following the Company’s initial public offering (the “IPO”) in mid-February of …
Virpax Pharmaceuticals Provides Progress Update on Product Candidates Read More BERWYN, PA — Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX), announced that the Investigational New Drug (IND) Application enabling studies for Envelta™ being performed under a Cooperative Research and Development Agreement (CRADA) …
Virpax to Use Envelta IND Enabling Study Results for Two Additional Indications Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Janssen …
FDA and CDC Lift Pause on Johnson & Johnson COVID-19 Vaccine Read More COATESVILLE, PA — Following the recommendation of the Centers for Disease Control & Prevention (CDC) and the Food and Drug Administration (FDA), the Coatesville Veterans Affairs Medical Center continues to …
Johnson & Johnson COVID-19 Vaccine Paused at Coatesville VA Medical Center Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal …
FDA Warns Companies Illegally Selling Over-the-Counter CBD Products for Pain Relief Read More